4,072 results match your criteria: "Geneva University Hospital.[Affiliation]"

Objective: Radiographic assessment of sacroiliac joints (SIJs) according to the modified New York (mNY) criteria is key in the classification of axial spondyloarthritis but has moderate interreader agreement. We aimed to investigate the improvements of the reliability in scoring SIJ radiographs after applying an online real-time iterative calibration (RETIC) module, in addition to a slideshow and video alone.

Methods: Nineteen readers, randomized to 2 groups (A or B), completed 3 calibration steps: (1) review of manuscripts, (2) review of slideshow and video with group A completing RETIC, and (3) re-review of slideshow and video with group B completing RETIC.

View Article and Find Full Text PDF

The great success of chimeric antigen receptor (CAR) T-cell therapy in the treatment of patients with B-cell malignancies has prompted its translation to solid tumors. In the case of glioblastoma (GBM), clinical trials have shown modest efficacy, but efforts to develop more effective anti-GBM CAR T cells are ongoing. In this study, we selected protein tyrosine phosphatase receptor type Z (PTPRZ1) as a target for GBM treatment.

View Article and Find Full Text PDF

Layer 5 extratelencephalic (ET) neurons are present across neocortical areas and send axons to multiple subcortical targets. Two cardinal subtypes exist: (1) Slco2a1-expressing neurons (ET), which predominate in the motor cortex and project distally to the pons, medulla and spinal cord; and (2) Nprs1- or Hpgd-expressing neurons (ET), which predominate in the visual cortex and project more proximally to the pons and thalamus. An understanding of how area-specific ET and ET emerge during development is important because they are critical for fine motor skills and are susceptible to spinal cord injury and amyotrophic lateral sclerosis.

View Article and Find Full Text PDF

An abnormal platelet count (PC) is common in acute venous thromboembolism (VTE) but its relationship with clinical outcomes remains ill-defined. We aimed to explore the association between baseline PC and the long-term risk of clinically relevant outcomes in a prospective cohort of 991 patients with acute VTE. We classified patients into four PC groups: very low (< 100 G/l), low (≥ 100 to < 150 G/l), normal (≥ 150 G/l to ≤ 450 G/l), and high (> 450 G/l).

View Article and Find Full Text PDF
Article Synopsis
  • - The text discusses the lack of strong clinical evidence in the critical care of ECMO patients with acute brain injury (ABI) and presents guidelines for their neurological care.
  • - Guidelines were developed using input from an international panel of 30 ECMO experts through a structured voting process, focusing on five key clinical areas.
  • - The consensus emphasizes the importance of early detection and intervention for ABI in ECMO patients to improve health outcomes and outlines multiple recommendations to guide clinical practice and highlight research needs.
View Article and Find Full Text PDF
Article Synopsis
  • The main treatment for immune-mediated thrombotic thrombocytopenic purpura (iTTP) in children includes therapeutic plasma exchange (TPE), corticosteroids, and rituximab, while caplacizumab is used for older children and adults, but its use for those under 12 is not officially approved.
  • A case study of a 7-year-old girl with iTTP showed successful treatment with caplacizumab after adjusting the dose according to her ADAMTS13 activity, leading to significant clinical improvement and full recovery without major side effects.
  • The review of existing literature revealed five cases of iTTP in children under 12 treated with caplacizumab, all showing success and safety,
View Article and Find Full Text PDF

The current study aimed to predict lymphovascular invasion (LVI) using multiple machine learning algorithms and multi-segmentation positron emission tomography (PET) radiomics in non-small cell lung cancer (NSCLC) patients, offering new avenues for personalized treatment strategies and improving patient outcomes. One hundred and twenty-six patients with NSCLC were enrolled in this study. Various automated and semi-automated PET image segmentation methods were applied, including Local Active Contour (LAC), Fuzzy-C-mean (FCM), K-means (KM), Watershed, Region Growing (RG), and Iterative thresholding (IT) with different percentages of the threshold.

View Article and Find Full Text PDF

Purpose: This study demonstrates the feasibility and benefits of using a deep learning-based approach for attenuation correction in [ 68 Ga]Ga-PSMA PET scans.

Methods: A dataset of 700 prostate cancer patients (mean age: 67.6 ± 5.

View Article and Find Full Text PDF

Importance: Previous studies investigated atherosclerotic changes induced by lipid-lowering therapy in extensive coronary segments irrespective of baseline disease burden (a vessel-level approach).

Objective: To investigate the effects of lipid-lowering therapy on coronary lesions with advanced atherosclerotic plaque features and presumably higher risk for future events.

Design, Setting, And Participants: The PACMAN-AMI randomized clinical trial (enrollment: May 2017 to October 2020; final follow-up: October 2021) randomized patients with acute myocardial infarction to receive alirocumab or placebo in addition to high-intensity statin therapy.

View Article and Find Full Text PDF

Background And Aims: Circulating proenkephalin (PENK) is a stable endogenous polypeptide with fast response to glomerular dysfunction and tubular damage. This study examined the predictive value of PENK for renal outcomes and mortality in patients with acute coronary syndrome (ACS).

Methods: Proenkephalin was measured in plasma in a prospective multicentre ACS cohort from Switzerland (n = 4787) and in validation cohorts from the UK (n = 1141), Czechia (n = 927), and Germany (n = 220).

View Article and Find Full Text PDF

Immune checkpoint inhibitors are standard-of-care for the treatment of advanced melanoma, but their use is limited by immune-related adverse events. Proteomic analyses and multiplex cytokine and chemokine assays from serum at baseline and at the adverse event onset indicated aberrant T cell activity with differential expression of type I and III immune signatures. This was in line with the finding of an increase in the proportion of CD4 T cells with IL-17A expression at the adverse event onset in the peripheral blood using flow cytometry.

View Article and Find Full Text PDF

Embracing the challenges of neonatal and paediatric pulmonary hypertension.

Eur Respir J

October 2024

Center for Congenital Heart Diseases, Paediatric and Congenital Cardiology, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Paediatric pulmonary arterial hypertension (PAH) shares common features with adult disease, but is associated with several additional disorders and challenges that require unique approaches. This article discusses recent advances, ongoing challenges and distinct approaches for caring for infants and children with PAH, as presented by the paediatric task force of the 7th World Symposium on Pulmonary Hypertension. We provide updates on diagnosing, classifying, risk-stratifying and treating paediatric pulmonary hypertension (PH) and identify critical knowledge gaps.

View Article and Find Full Text PDF

Contrast-Enhancing Lesion Segmentation in Multiple Sclerosis: A Deep Learning Approach Validated in a Multicentric Cohort.

Bioengineering (Basel)

August 2024

Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel, University of Basel, 4123 Basel, Switzerland.

The detection of contrast-enhancing lesions (CELs) is fundamental for the diagnosis and monitoring of patients with multiple sclerosis (MS). This task is time-consuming and suffers from high intra- and inter-rater variability in clinical practice. However, only a few studies proposed automatic approaches for CEL detection.

View Article and Find Full Text PDF

Evolving and Improving the Sustainability of Molecular Tumor Boards: The Value and Challenges.

Cancers (Basel)

August 2024

Pathology Unit 2, Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.

The increasing volume of information for cancer care, and the evolution of molecularly guided therapies, have increased the need for molecular tumor boards (MTBs), which can integrate such data into personalized treatment plans to improve patient outcomes. However, recommendations for improving the sustainability of MTBs are lacking. A diverse committee of MTB experts was assembled (February-March 2023), with extensive experience in sustainability in healthcare ecosystems.

View Article and Find Full Text PDF

Advances in Personalized Oncology.

Cancers (Basel)

August 2024

Clinique Générale Beaulieu, 1206 Geneva, Switzerland.

Article Synopsis
  • * Targeted therapies and companion diagnostics are crucial for matching treatments to specific genetic mutations found through NGS, but understanding the significance of various mutations is complex.
  • * The development of molecular tumor boards is helping integrate genomic data into clinical practice, enhancing personalized treatment strategies and ultimately improving patient outcomes.
View Article and Find Full Text PDF

Evaluation of non-invasive biomarkers of kidney allograft rejection in a prospective multicenter unselected cohort study (EU-TRAIN).

Kidney Int

November 2024

Université Paris Cité, INSERM U970, Paris Institute for Transplantation and Organ Regeneration, Paris, France; Department of Kidney Transplantation, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France. Electronic address:

Non-invasive biomarkers are promising tools for improving kidney allograft rejection monitoring, but their clinical adoption requires more evidence in specifically designed studies. To address this unmet need, we designed the EU-TRAIN study, a large prospective multicentric unselected cohort funded by the European Commission. Here, we included consecutive adult patients who received a kidney allograft in nine European transplant centers between November 2018 and June 2020.

View Article and Find Full Text PDF

Oncolytic virus and tumor-associated macrophage interactions in cancer immunotherapy.

Clin Exp Med

August 2024

Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, Hong Kong University, Hong Kong, China.

Oncolytic viruses (OV) are a promising strategy in cancer immunotherapy. Their capacity to promote anti-tumoral immunity locally raises hope that cancers unresponsive to current immunotherapy approaches could be tackled more efficiently. In this context, tumor-associated macrophages (TAM) must be considered because of their pivotal role in cancer immunity.

View Article and Find Full Text PDF

Background: In Sub-Saharan Africa, which already faces challenges due to a lack of surgeons and facilities, the COVID-19 pandemic could significantly disrupt surgical activities and training programs. "2 Chance", a non-governmental organization providing training program to enhance local reconstructive surgery capacity in this region since 2015, could play a crucial role in addressing these issues. We aimed to investigate the impact of the COVID-19 on the activity of sub-Saharan African reconstructive surgeons collaborating with "2 Chance" organization and evaluate its effect on the organization's training programs.

View Article and Find Full Text PDF

Purpose: Non-small cell lung cancer is the most common subtype of lung cancer. Patient survival prediction using machine learning (ML) and radiomics analysis proved to provide promising outcomes. However, most studies reported in the literature focused on information extracted from malignant lesions.

View Article and Find Full Text PDF

Improving prognostication of pneumonia among elderly patients: usefulness of suPAR.

BMC Geriatr

August 2024

Division of Geriatric Medicine, Department of Rehabilitation and Geriatrics Medicine, Geneva University Hospitals, Thônex, Switzerland.

Purpose: Elderly patients with suspected pneumonia represent a significant proportion of hospital admissions, which is a prognostic challenge for physicians. Our research aimed to assess the prognosis of patients with pneumonia using soluble urokinase plasminogen activator receptor (suPAR) combined with clinical data.

Methods: In a prospective observational study including 164 patients > 65 years (mean age 84.

View Article and Find Full Text PDF

An efficient dual-domain deep learning network for sparse-view CT reconstruction.

Comput Methods Programs Biomed

November 2024

Geneva University Hospital, Division of Nuclear Medicine and Molecular Imaging, CH-1211 Geneva, Switzerland; Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, Netherlands; Department of Nuclear Medicine, University of Southern Denmark, Odense, Denmark; University Research and Innovation Center, Óbuda University, Budapest, Hungary. Electronic address:

Article Synopsis
  • Developed an efficient dual-domain deep-learning method for sparse-view CT reconstruction with minimal training parameters and comparable running time.
  • Designed two lightweight networks, Sino-Net and Img-Net, to restore projection and image signals, tested using clinical thoraco-abdominal CT data.
  • Results indicated the algorithm effectively reduced noise and artifacts, restored fine details, and improved overall image quality, showcasing its potential for practical clinical use.
View Article and Find Full Text PDF
Article Synopsis
  • Degenerative cervical myelopathy (DCM) affects about 2% of adults, and there is a lack of standardized outcomes in clinical research, leading to inconsistencies in study results; creating a standardized minimum data set could enhance comparability.* -
  • The study used a modified Delphi method to develop a core outcome set (COS), core data elements (CDEs), and a core measurement set (CMS) for DCM research, with input from an international stakeholder group.* -
  • In total, 28 outcomes were identified across 6 key domains, culminating in a structured data set that can be utilized in future clinical trials to ensure consistency and improve measurement accuracy in DCM research.*
View Article and Find Full Text PDF
Article Synopsis
  • * Data from 459 patients with vessel perforation showed a 90-day mortality rate of 51.9%, with only 16.3% achieving a favorable recovery (mRS 0-2).
  • * The findings indicate that large vessel perforation leads to worse outcomes, while thrombolysis doesn’t worsen prognoses; quick management of bleeding is crucial for survival.
View Article and Find Full Text PDF

ECMP 2022 special issue editorial.

Phys Med

September 2024

Division of Medical Radiation Physics and Department of Radiation Oncology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.

View Article and Find Full Text PDF